New Patient Special: No charge for the Tear Film Diagnostics for all new dry eye exams ($95 discount). Offer expires: 12/31/23
blog-top-bg-new

Rosacea in the Eye?

Many of us may be familiar with facial rosacea, but ocular rosacea is a common ocular finding with dry eye disease. Ocular rosacea is a condition in which leaky abnormal blood vessels appear on the lid margins. These abnormal blood vessels contribute to inflammation on the ocular surface, decreased meibomian gland function which can then lead to destabilized tear film and red, irritated eyes. This lid inflammation can also make you more prone to styes.

The Lumenis Optilight Intense Pulsed Light Therapy (IPL) is the first FDA approved IPL device for dry eye. With this advanced technology, we are able to lower the inflammatory mediators exposed to the ocular surface by destroying abnormal blood vessels, decreasing demodex bacterial load and restoring meibomian gland function. By improving the function of the glands, IPL therapy can help improve the quality of the tears and reduce tear evaporation, which can help prevent further damage to the eyes. 

IPL therapy is a non-invasive treatment that is quick and convenient and patients can typically resume their normal activities immediately following the treatment. However, it is important to wear good quality sunscreen throughout the course of the treatments. In addition, hats and sunglasses are recommended with prolonged sun exposure. With this form of light therapy we are able to ensure the meibomian glands are working at their best potential and slow down further progression of dry eye disease.

Recent Posts

Ocular Neuropathic Pain

Ocular neuropathic pain is suspected when dry eye symptoms are more extreme and heightened relative...

Read More
Why Do I Wake Up...

Dry eye disease is a common condition that occurs when the eyes do not produce...

Read More
What is Low-level Light Therapy?

Low-level light therapy (LLLT), also known as photobiomodulation, has been proposed as a treatment for...

Read More